Investigations
We examine advertising promises, sales terms and pressure tactics so you can decide without rushing.
Otovitalor for hearing and tinnitus: what the advert says and what it proves
Otovitalor is marketed in Germany for hearing and tinnitus. We check its ingredients, the “1*” price, a cited paper and urgent care guidance.
SugarMD Advanced Glucose Support: FDA found hidden diabetes drugs
FDA testing found glyburide and metformin in Dr. Ergin’s SugarMD Advanced Glucose Support. The agency says not to buy or use any of it.
Ultra Bon: FDA found diclofenac missing from the label
FDA says not to buy or use Ultra Bon after lab analysis found undeclared diclofenac. A separate Mexico listing is not confirmed as the tested sample.
Insufree drops in Brazil: Anvisa banned the P2 Brasil product
Brazil’s Anvisa banned all lots of P2 Brasil’s Insufree drops over unknown origin and therapeutic claims. Here is what the notice proves—and what it does not.
Kama Super Platinum in Australia: TGA found undeclared prescription drugs
Australia’s TGA says a tested Kama Super Platinum sample contained undeclared sildenafil and dapoxetine. See the safety warning and its limits.
Newfit: Brazil’s regulator found three undeclared medicines
Anvisa banned every Newfit lot after testing identified sibutramine, fluoxetine and furosemide missing from the label. Here is what the evidence shows.
Glicojax and diabetes: Brazil’s regulator banned the product
Brazil’s Anvisa banned Glicojax over unknown origin and unsubstantiated diabetes claims. Here is what the official order establishes—and what it does not.
Durasil drops: Brazil banned the supplement with unknown origin
Anvisa banned every lot of the Durasil drops in Brazil: the origin and manufacturer were unknown, and ads promised pain relief and better erections.
HYM and DIABHYM: Mexico’s COFEPRIS warns of counterfeits
Mexico’s COFEPRIS classifies HYM and DIABHYM as counterfeit supplements. Here is what its alert establishes—and what it does not.
Glamorous Fire: Brazil’s Anvisa banned these capsules
Anvisa banned every lot of Glamorous Fire capsules: the company was unknown, and ads claimed blood-sugar and stress benefits.